Shed vs BreezeMeds: Coaching and compounded options vs oral choices
Shed vs BreezeMeds compares two telehealth weight-loss options with different strengths. Quick verdict: Shed stands out if you want integrated coaching plus access to both name-brand and compounded GLP-1; BreezeMeds is notable for listing injectable and oral GLP-1 choices with discreet shipping and pricing starting at $199.
Start Shed’s 2-minute assessment
How they differ at a glance
Both providers require a licensed clinician to determine medical appropriateness. The most distinctive supported differences are: medication breadth (name-brand plus compounded at Shed versus injectable and oral options at BreezeMeds), coaching integration, clear promotional pricing, compounded medication regulatory notes, and shipping or discretion claims.
Medication options: name-brand and compounded vs injectable and oral
Shed offers both FDA-approved name-brand GLP-1 medications and compounded GLP-1 options on one platform, including compounded semaglutide and compounded tirzepatide. The source explicitly notes that compounded medications are not FDA-approved and are prepared by a licensed pharmacy based on a provider’s prescription. BreezeMeds lists semaglutide and tirzepatide injections and also displays oral semaglutide and oral tirzepatide from $399. BreezeMeds captures both injectable and oral formats in its landing evidence.
What that means
Shed gives a single platform choice between branded and compounded formulations, while BreezeMeds emphasizes availability of both injectable and oral formulations and lists a range of starting prices including $199 and $399 figures.
Coaching and support versus discreet delivery
Shed integrates continuous coaching into treatment so coaching is bundled into the monthly cost rather than offered as an optional add-on, and the platform states coaching supports titration, lifestyle changes, and plateaus. BreezeMeds highlights discreet home delivery and ongoing support and frames its offering around discreet shipping and personalized plans.
See BreezeMeds treatment options
Pricing and promotions with preserved qualifiers
Shed lists compounded semaglutide injections starting at $199/month and compounded tirzepatide injections starting at $299/month and advertises 10% off your first month as a limited time offer. Shed also notes that standard pricing is not published and that you receive a personalized quote after intake. BreezeMeds shows starting prices including semaglutide injection from $199/mo, tirzepatide injection from $299, and oral options displayed from $399. A separate $169 figure appears on BreezeMeds without a clear product association.
Regulatory and clinician review notes
Both providers make clear treatment is available only when a licensed clinician determines it is medically appropriate. The Shed source explicitly states that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. BreezeMeds’ evidence says medication-specific approval status must be confirmed and that branded and compounded products are not interchangeable.
Comparison table
| Criteria | Shed | BreezeMeds |
|---|---|---|
| Medication types | Name-brand and compounded GLP-1 options | Injectable and oral semaglutide and tirzepatide shown |
| Coaching | Continuous coaching integrated into treatment | Ongoing support mentioned with personalized plan |
| Starting price | Compounded semaglutide starting at $199/month; tirzepatide starting at $299/month; 10% off first month | Semaglutide injection from $199/mo; tirzepatide injection from $299; oral options from $399; $169 figure unclear |
| Compounded status | Compounded meds not FDA-approved; prepared by a licensed pharmacy | Compounding and FDA status require confirmation; not interchangeable with branded products |
| Shipping and delivery | Medication shipped after clinician review; membership and shipping details linked to terms | Discreet home delivery emphasized |
Which provider is best for your priorities
Use the table above to match your priorities. If you value built-in behavioral support and the option to choose between branded and compounded formulations, the evidence supports Shed. If you specifically need or prefer an oral GLP-1 option or explicit emphasis on discreet delivery and visible starting prices for injectables and orals, BreezeMeds lists those formats and prices.
Begin Shed intake and coaching details
Shed vs BreezeMeds: final guidance
Primary keyword: Shed vs BreezeMeds
Choose Shed if you want integrated continuous coaching and access to both FDA-approved name-brand GLP-1 and compounded alternatives, with a 2-minute approval assessment and a stated limited time 10% off your first month. Choose BreezeMeds if you need a provider that displays injectable and oral GLP-1 formats with starting prices shown and emphasizes discreet home delivery, while confirming that some price figures and product associations may require clarification.